Valuation: InfuSystem Holdings, Inc.

Market Cap 249M 216M 202M 184M 347M 23.7B 353M 2.36B 926M 11.86B 934M 914M 39.63B P/E 2026 *
29x
P/E 2027 * 22.3x
Enterprise Value 249M 216M 202M 184M 347M 23.7B 353M 2.36B 926M 11.86B 934M 914M 39.63B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
92.49%
Yield 2026 *
-
Yield 2027 * -
1 day-2.96%
1 week+32.60%
Current month+32.60%
1 month+24.44%
3 months+44.11%
6 months+58.22%
Current year+35.12%
1 week 9.88
Extreme 9.875
12.97
1 month 8.69
Extreme 8.6901
12.97
Current year 7.29
Extreme 7.29
12.97
1 year 7.29
Extreme 7.29
12.97
3 years 4.61
Extreme 4.61
12.97
5 years 4.61
Extreme 4.61
19.9
10 years 1.2
Extreme 1.2
23.26
Manager TitleAgeSince
Chief Executive Officer 49 2025-05-18
Director of Finance/CFO 55 2020-03-11
Chief Tech/Sci/R&D Officer 47 -
Director TitleAgeSince
Chairman 60 2018-12-18
Director/Board Member 64 2019-05-14
Director/Board Member 49 2021-03-17
Date Insider Type Main position Quantity % Market Cap.
5/18/26 Fiscal year

Chief Financial Officer

21,230 0.1050%
10/9/25 Other

Head of Human Resources

28,669 0.1348%
9/23/25 Other

Chief Executive Officer

69,675 0.3277%
Change 5-day change 1-year change 3-year change Capi.($)
-2.96%+32.60%+37.26%+7.83% 249M
+0.75%+2.76%-19.11%+3.15% 187B
+2.58%+4.71%-3.74%+7.80% 112B
+1.42%+4.39%+13.98%+75.00% 61.15B
+2.38%+6.38%+35.52%+59.33% 54.39B
+1.57%+8.46%-7.17%-36.20% 48.17B
+3.42%+5.03%+11.15%-21.01% 31.98B
-4.03%-13.93% - - 30.91B
-0.55%+3.28%+46.12%-12.00% 24.92B
+0.61%+4.60%-1.62%+5.26% 23.15B
Average +0.52%+0.29%+12.49%+9.91% 57.3B
Weighted average by Cap. +1.23%+2.08%-0.12%+12.32%

Financials

2026 *2027 *
Net sales 145M 126M 118M 108M 203M 13.85B 206M 1.38B 541M 6.93B 545M 534M 23.15B 156M 135M 126M 115M 217M 14.83B 221M 1.48B 579M 7.42B 584M 572M 24.79B
Net income 9.54M 8.26M 7.73M 7.06M 13.29M 909M 13.52M 90.42M 35.5M 455M 35.8M 35.03M 1.52B 11.69M 10.13M 9.47M 8.65M 16.29M 1.11B 16.57M 111M 43.52M 557M 43.88M 42.94M 1.86B
Net Debt - -
Logo InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Employees
467
Date Price Change Volume
26-08-10 US$12.12 -2.96% 200,409
26-08-07 US$12.49 +5.22% 199,528
26-08-06 US$11.87 -2.30% 182,503
26-08-05 US$12.15 -1.38% 443,876
26-08-04 US$12.32 +33.62% 582,072
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.49USD
Average target price
17.62USD
Spread / Average Target
+41.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INFU Stock